Results of previous studies that explored both, neurofilament light chain (NfL) and neurofilament heavy chain (NfH), as blood biomarkers in different types of SMA are inconclusive, depending on the subtype.9, 11. This evidence concerns the gene NEFL and proximal spinal muscular atrophy.